Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia (Q84261845)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

title

Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

main subject

chronic myeloid leukemia

1 reference

Catherine Roche-Lestienne

inferred from title

author

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

Alice Marceau-Renaut

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

Olivier Nibourel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

Claude Preudhomme

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

16

Fi-LMC group

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

author name string

E Labis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

V Coiteux

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

J Guilhot

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

L Legros

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

F Nicolini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

P Rousselot

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

M Gardembas

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

N Helevaut

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

C Frimat

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

F-X Mahon

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

F Guilhot

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

publication date

3 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

1661-1664

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637286 AND SRC:MED&resulttype=core&format=json

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.139

7 January 2021

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.139

7 January 2021

Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.139

7 January 2021

Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.139

7 January 2021

Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.139

7 January 2021

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.139

7 January 2021

IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.139

7 January 2021

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.139

7 January 2021